Qiagen said Wednesday it is seeking emergency FDA clearance for its coronavirus diagnostic. Separately, Gilead started a pair of Phase III trials of remdesivir to treat COVID-19, ...

Vanda shares Wednesday mostly shrugged off a sharp decline in after-hours trading Tuesday after tradipitant missed the primary endpoint in the Phase III EPIONE trial to treat ...

Takeda gains another celiac candidate via PvP takeout

After PvP Biologics Inc. finished a Phase I trial demonstrating proof of concept of its celiac disease therapy, ...

WindMIL is developing cancer therapies using bone marrow-derived T cells, which could be more persistent than tumor-infiltrating lymphocytes and hit a broader range of antigens ...

As China responds to the COVID-19 outbreak, the country’s ministries of Science and Technology and Education have issued guidance that aims to reduce of the focus of academic ...